187 related articles for article (PubMed ID: 21913804)
1. Differential expression and signaling activation of insulin receptor isoforms A and B: A link between breast cancer and diabetes.
Kalla Singh S; Brito C; Tan QW; De León M; De León D
Growth Factors; 2011 Dec; 29(6):278-89. PubMed ID: 21913804
[TBL] [Abstract][Full Text] [Related]
2. Quantifying insulin receptor isoform expression in FFPE breast tumors.
Harrington SC; Weroha SJ; Reynolds C; Suman VJ; Lingle WL; Haluska P
Growth Horm IGF Res; 2012; 22(3-4):108-15. PubMed ID: 22551578
[TBL] [Abstract][Full Text] [Related]
3. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
4. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
[TBL] [Abstract][Full Text] [Related]
5. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.
Lero MW; Shaw LM
Mol Cell Endocrinol; 2021 May; 527():111213. PubMed ID: 33607269
[TBL] [Abstract][Full Text] [Related]
6. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.
Chan JY; Hackel BJ; Yee D
Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775
[TBL] [Abstract][Full Text] [Related]
7. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
[TBL] [Abstract][Full Text] [Related]
8. Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation.
Gong Y; Ma Y; Sinyuk M; Loganathan S; Thompson RC; Sarkaria JN; Chen W; Lathia JD; Mobley BC; Clark SW; Wang J
Neuro Oncol; 2016 Jan; 18(1):48-57. PubMed ID: 26136493
[TBL] [Abstract][Full Text] [Related]
9. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
[TBL] [Abstract][Full Text] [Related]
10. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
[TBL] [Abstract][Full Text] [Related]
11. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
[TBL] [Abstract][Full Text] [Related]
12. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
13. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
15. Quantification of insulin receptor mRNA splice variants as a diagnostic tumor marker in breast cancer.
Aljada A; Saleh AM; Al-Aqeel SM; Shamsa HB; Al-Bawab A; Al Dubayee M; Ahmed AA
Cancer Biomark; 2015; 15(5):653-61. PubMed ID: 26406954
[TBL] [Abstract][Full Text] [Related]
16. Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity.
Kalla Singh S; Tan QW; Brito C; De León M; Garberoglio C; De León D
Growth Horm IGF Res; 2010 Apr; 20(2):162-70. PubMed ID: 20089431
[TBL] [Abstract][Full Text] [Related]
17. Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.
Becker MA; Hou X; Tienchaianada P; Haines BB; Harrington SC; Weroha SJ; Sathyanarayanan S; Haluska P
BMC Cancer; 2016 Oct; 16(1):814. PubMed ID: 27765027
[TBL] [Abstract][Full Text] [Related]
18. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
19. Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells.
ter Braak B; Wink S; Koedoot E; Pont C; Siezen C; van der Laan JW; van de Water B
Breast Cancer Res; 2015 Jul; 17(1):97. PubMed ID: 26187749
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
